CNTX icon

Context Therapeutics
CNTX

Overview Fund Activity

22 hedge funds and large institutions have $723K invested in Context Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$31.3K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$13.8K
3
SSWM
3
Sheets Smith Wealth Management
North Carolina
$11.2K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$9.11K
5
BBA
5
Baader Bank Aktiengesellschaft
Germany
$4.67K

Top Sellers

1
ACM
1
AIGH Capital Management
Maryland
$0
2
AAA
2
Affinity Asset Advisors
New York
$0
3
WVP
3
Worth Venture Partners
New Jersey
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$11K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$322K
Name Holding Trade Value Shares
Change 		Shares
Change %
TSS
26
Two Sigma Securities
New York
– -$12.6K -19,350 Closed
1
2